Clinical Trials Browser

Phase 1 × Solid Tumor × HLX07 × Clear all

NCT05360368 2022-05-05

HLX07(Anti-EGFR mAb) in Patients With Advanced or Metastatic Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor